Hidefumi Kasuga
HK
Ph.D.
Hidefumi Kasuga
Ph.D.
About
Dr. Hidefumi Kasuga joined Taiho Ventures in 2022, bringing extensive experience in oncology drug discovery and development, with a specialization in developing compounds targeting the epidermal growth factor receptor (EGFR).
Score Breakdown
14Influence
0Track Record
28Visibility
8Profile
50Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
Who is Hidefumi Kasuga?
Dr. Hidefumi Kasuga joined Taiho Ventures in 2022, bringing extensive experience in oncology drug discovery and development, with a specialization in developing compounds targeting the epidermal growth factor receptor (EGFR).
What is Hidefumi Kasuga's current role?
Hidefumi Kasuga is currently Ph.D..
Contact Info
Similar People